Leukaemia inhibitory factor abrogates Paclitaxel-induced axonal atrophy in the Wistar rat
Details
Publication Year 2001-08-24,Volume 911,Issue #2,Page 163-167
Journal Title
BRAIN RESEARCH
Publication Type
Journal Article
Abstract
A prominent side effect of Paclitaxel chemotherapy is sensorimotor peripheral neuropathy. Leukaemia inhibitory factor (LIF) supports the survival and regrowth of axotomised sensory and motor neurons and we therefore investigated if systemically administered LIF abrogated Paclitaxel-induced neuropathy. We found that whereas animals administered Paclitaxel alone exhibited a significant decrease in the percentage of large myelinated axons, this reduction was prevented by the co-administration of LIF. (C) 2001 Elsevier Science B.V. All rights reserved.
Publisher
ELSEVIER SCIENCE BV
Keywords
TAXOL; NEUROPATHY; DEATH
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2001-08-24 12:00:00
An error has occurred. This application may no longer respond until reloaded. Reload 🗙